samedan logo
 
 
spacer
home > ebr > winter 2002 > new challenges in physiogenomics
PUBLICATIONS
European BioPharmaceutical Review

New Challenges in Physiogenomics

Organising, validating and selecting the relevant information is the key to making the right decisions during drug, and other, development. Understanding complex disease pathways by observing the function and interaction of genes (physiogenomics), and discovering new targets and lead candidates has become a major challenge now that massive amounts of information are available through the various high-throughput technologies.This article discusses new tools, including bioinformatics, that overcome existing limitations such as reproducibility, sensitivity and specificity for data analysis, disease space identification, drug development and patient clustering. In the genomic age, the rapid discovery of new therapeutic strategies for multi-factorial diseases relies on the identification and comparison of correlates and cross talks between functional pathways in human and animal models. Understanding these pathways that drive the progression of complex pathologies at cellular and molecular levels, is now perceived as the new challenge of modern physiogenomics.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Nora Benhabilès, Director of Bioinformatics, and Professor Gérard Marguerie, Chief Scientific Officer, at CliniGenetics Dr Nora Benhabilès received her PhD in Molecular Biophysics from the University Pierre et Marie Curie (Paris VI). She worked in several leading European bioinformatics centres before joining CliniGenetics.
Dr Benhabilès is a recognised expert in molecular modelling, structural genomics and statistical methods, and has worked on protein folding, protein sequence analysis, protein structure prediction and molecular dynamics on DNA. In particular, she is active in setting up clustering methods and neural networks applied to post-genomics data. She is an adjunct Professor at the University of Paris teaching molecular modelling, bioinformatics and programming.

Professor Gérard Marguerie holds a PhD in Biophysics and Cell Biology. He is a former Director of Research at the National Center for Scientific Research (CNRS). He then spent three years at the Scripps Clinic in San Diego and was appointed as Director of an INSERM unit in Haematology on returning to France.

Professor Marguerie then took a CEA (Atomic Energy Agency) appointment as Director of the Department of Structural and Molecular Biology at the Nuclear Centre of Research in Grenoble. He was also appointed as the Co-Director of the National Programme on Structural Biology. Professor Marguerie was a substitute Director of the Life Sciences Division of the Atomic Energy Agency, Head of a Functional Genomic Research Unit, and Professor at Evry University (Paris) in cellular biology.


spacer
Dr Nora Benhabilès
spacer
spacer
spacer
Professor Gérard Marguerie
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EuroBiopartnering 2008

7-9 October 2008, Paris, France

EuroBiOpartnering 2008 gives you the unique opportunity to meet the relevant decision makers and opinion leaders from the international biotech community and offers you 3 days of partnering opportunities including one-to-one meetings, company presentations and further networking activities…
More info >>

 
News and Press Releases

Ultra slim and ultra quick


More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement